DK1899334T3 - Naphthyridinforbindelser - Google Patents
NaphthyridinforbindelserInfo
- Publication number
- DK1899334T3 DK1899334T3 DK06773519T DK06773519T DK1899334T3 DK 1899334 T3 DK1899334 T3 DK 1899334T3 DK 06773519 T DK06773519 T DK 06773519T DK 06773519 T DK06773519 T DK 06773519T DK 1899334 T3 DK1899334 T3 DK 1899334T3
- Authority
- DK
- Denmark
- Prior art keywords
- sub
- histamine
- receptor
- naphthyridine
- serotonin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Otolaryngology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69200305P | 2005-06-17 | 2005-06-17 | |
| PCT/US2006/023788 WO2006138714A2 (en) | 2005-06-17 | 2006-06-16 | Naphthyridine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1899334T3 true DK1899334T3 (da) | 2008-11-24 |
Family
ID=37263777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06773519T DK1899334T3 (da) | 2005-06-17 | 2006-06-16 | Naphthyridinforbindelser |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US7417054B2 (de) |
| EP (1) | EP1899334B1 (de) |
| JP (1) | JP2008543880A (de) |
| CN (1) | CN101243083A (de) |
| AT (1) | ATE409188T1 (de) |
| AU (1) | AU2006261162A1 (de) |
| CA (1) | CA2612409A1 (de) |
| DE (1) | DE602006002894D1 (de) |
| DK (1) | DK1899334T3 (de) |
| ES (1) | ES2314933T3 (de) |
| PL (1) | PL1899334T3 (de) |
| PT (1) | PT1899334E (de) |
| SI (1) | SI1899334T1 (de) |
| WO (1) | WO2006138714A2 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030078347A1 (en) * | 2001-08-28 | 2003-04-24 | General Electric Company | Triazine compounds, polymers comprising triazine structural units, and method |
| EA200801812A1 (ru) * | 2003-09-17 | 2009-06-30 | Янссен Фармацевтика Н.В. | Сопряженные гетероциклические соединения |
| WO2006138604A1 (en) * | 2005-06-17 | 2006-12-28 | Janssen Pharmaceutica N.V. | Hexahydro-pyrrolo-isoquinoline compounds for the treatment of cns disorders |
| US7598255B2 (en) * | 2005-08-04 | 2009-10-06 | Janssen Pharmaceutica Nv | Pyrimidine compounds as serotonin receptor modulators |
| AU2007265240A1 (en) * | 2006-06-29 | 2008-01-03 | Janssen Pharmaceutica N.V. | Substituted aminomethyl benzamide compounds |
| CN101511775A (zh) * | 2006-06-29 | 2009-08-19 | 詹森药业有限公司 | 丁基和丁炔基苄基胺化合物 |
| AU2007265242A1 (en) * | 2006-06-29 | 2008-01-03 | Janssen Pharmaceutica N.V. | Substituted benzyl amine compounds |
| FR2903904A1 (fr) * | 2006-07-21 | 2008-01-25 | Bioprojet Soc Civ Ile | Association de modafinil et d'un antagoniste ou agoniste inverse du recepteur h3 |
| TW200823204A (en) * | 2006-10-17 | 2008-06-01 | Arena Pharm Inc | Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine H3-receptor useful for the treatment of disorders related thereto |
| US20080139564A1 (en) * | 2006-11-16 | 2008-06-12 | Keith John M | Substituted phenyl propyl amines as histamine h3 receptor and serotonin transporter modulators |
| KR20090127307A (ko) | 2007-03-01 | 2009-12-10 | 얀센 파마슈티카 엔.브이. | 히스타민 ｈ３ 수용체 조절제로서의 테트라하이드로이소퀴놀린 화합물 |
| WO2008144305A1 (en) | 2007-05-18 | 2008-11-27 | Janssen Pharmaceutica N.V. | Diaryl-substituted tetrahydroisoquinolines as histamine h3 receptor and serotonin transporter modulators |
| JP2011518127A (ja) * | 2008-03-31 | 2011-06-23 | エヴォテック・アクチエンゲゼルシャフト | ヒスタミンｈ３受容体アンタゴニストとしてのテトラヒドロナフチリジンおよびそれらのアザ誘導体 |
| JP5364327B2 (ja) * | 2008-09-26 | 2013-12-11 | 富士フイルム株式会社 | ハロピラジンカルボキサミド化合物の製造方法 |
| CN113024456B (zh) * | 2021-02-23 | 2022-05-13 | 江苏先导药业有限公司 | 一种2-氯烟酸的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH538477A (de) * | 1970-01-06 | 1973-06-30 | Hoffmann La Roche | Verfahren zur Herstellung von Isochinolin-Derivaten |
| GB1504424A (en) | 1975-08-09 | 1978-03-22 | Beecham Group Ltd | Isoquinoline-derived aminoethers |
| GB1558043A (en) * | 1976-02-03 | 1979-12-19 | Onoda Cement Co Ltd | Metal squeeze out tube and method and apparatus for forming a powder layer on its surface |
| ES2203642T3 (es) * | 1995-06-07 | 2004-04-16 | Pfizer Inc. | Derivados de pirimidina heterociclicos con anillos condensados. |
| EP0978512A1 (de) | 1998-07-29 | 2000-02-09 | Societe Civile Bioprojet | Aryloxy- (oder Arylthio)alkylamine ohne Imidazolring als Histamin-H3-Antagonisten und deren therapeutische Anwendung |
| BR0015307A (pt) | 1999-11-03 | 2002-07-09 | Albany Molecular Res Inc | Composto, composição, composição farmacêutica, métodos para tratar um distúrbio que é criado pela ou é dependente da disponibilidade diminuìda de serotonina, norepinefrina ou dopamina, e para inibir a absorção de norepinefrina sináptica, de serotonina sináptica e de dopamina sináptica em um paciente em necessidade destas, e, conjunto |
| EP1113007A1 (de) | 1999-12-24 | 2001-07-04 | Pfizer Inc. | Tetrahydroisochinolin-Verbindungen zur Verwendung als Östrogen-Agonisten/-Antagonisten |
| EP1595881A1 (de) * | 2004-05-12 | 2005-11-16 | Pfizer Limited | Tetrahydronaphthyridin-Derivate, verwendbar als Histamin H3 Rezeptor-Liganden |
| WO2006066197A1 (en) | 2004-12-17 | 2006-06-22 | Janssen Pharmaceutica, N.V. | Tetrahydroisoquinoline compounds for treatment of cns disorders |
-
2006
- 2006-06-16 CA CA002612409A patent/CA2612409A1/en not_active Abandoned
- 2006-06-16 ES ES06773519T patent/ES2314933T3/es active Active
- 2006-06-16 AT AT06773519T patent/ATE409188T1/de not_active IP Right Cessation
- 2006-06-16 PT PT06773519T patent/PT1899334E/pt unknown
- 2006-06-16 PL PL06773519T patent/PL1899334T3/pl unknown
- 2006-06-16 EP EP06773519A patent/EP1899334B1/de not_active Not-in-force
- 2006-06-16 DE DE602006002894T patent/DE602006002894D1/de not_active Expired - Fee Related
- 2006-06-16 CN CNA200680030064XA patent/CN101243083A/zh active Pending
- 2006-06-16 US US11/424,751 patent/US7417054B2/en active Active
- 2006-06-16 WO PCT/US2006/023788 patent/WO2006138714A2/en active Application Filing
- 2006-06-16 SI SI200630141T patent/SI1899334T1/sl unknown
- 2006-06-16 DK DK06773519T patent/DK1899334T3/da active
- 2006-06-16 JP JP2008517211A patent/JP2008543880A/ja not_active Withdrawn
- 2006-06-16 AU AU2006261162A patent/AU2006261162A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006138714A3 (en) | 2007-03-15 |
| US7417054B2 (en) | 2008-08-26 |
| US20060287292A1 (en) | 2006-12-21 |
| PT1899334E (pt) | 2008-11-06 |
| AU2006261162A1 (en) | 2006-12-28 |
| WO2006138714A2 (en) | 2006-12-28 |
| EP1899334A2 (de) | 2008-03-19 |
| PL1899334T3 (pl) | 2009-04-30 |
| CA2612409A1 (en) | 2006-12-28 |
| ATE409188T1 (de) | 2008-10-15 |
| CN101243083A (zh) | 2008-08-13 |
| SI1899334T1 (sl) | 2009-04-30 |
| DE602006002894D1 (de) | 2008-11-06 |
| JP2008543880A (ja) | 2008-12-04 |
| ES2314933T3 (es) | 2009-03-16 |
| EP1899334B1 (de) | 2008-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1899334T3 (da) | Naphthyridinforbindelser | |
| ATE496892T1 (de) | Tetrahydroisochinolinverbindungen zur behandlung von zns-erkrankungen | |
| HK1118550A1 (en) | Fused heterocyclic compounds as serotonin receptor modulators | |
| ATE407927T1 (de) | 3-phenyl-pyrazol-derivate als modulatoren des zur behandlung damit zusammenhängender störungen nützlichen 5-ht-2a-serotonin-rezeptors | |
| EA200800525A1 (ru) | Соединения пиримидина в качестве модуляторов серотониновых рецепторов | |
| CY1117124T1 (el) | ΑΝΘΡΩΠΟΠΟΙΗΜΕΝΟΙ ANTΑΓΩΝΙΣΤΕΣ ΑΝΤΙ-β7 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ | |
| WO2008002820A3 (en) | Substituted benzyl amine compounds | |
| ATE461217T1 (de) | Glp-1-verbindungen | |
| AT9566U3 (de) | Kopierfräseinrichtung zur herstellung von zahntechnischen werkstücken | |
| EA201100062A1 (ru) | Соединения и способы модулирования рецепторов, связанных с белком g | |
| CR9365A (es) | Compuestos y metodos para la inhibicion de la protein-cinasa raf | |
| IS8530A (is) | Meðferð á truflunum í auga þar með talinni sjóndepilsrýrnun | |
| MY145305A (en) | Cyclopropyl amines as modulators of the histamine h3 receptor | |
| NO20055563L (no) | Midler for behandlingen av lavere abdominale lidelser | |
| ATE458740T1 (de) | 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen- derivate als orexinrezeptor-antagonisten | |
| CL2007000595A1 (es) | Compuestos derivados de piperidina; composicion farmaceutica y uso para el tratamiento y/o profilaxis de enfermedades seleccionadas entre hipertension, insuficiencia cardiaca congestiva e insuficiencia renal entre otras. | |
| CL2007002380A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica. | |
| DE602004014772D1 (de) | Pyrrol-2,5-dithionderivate als modulatoren des liver-x-rezeptors | |
| CL2008003659A1 (es) | Compuestos derivados de 6-(4-bencilpiperazin-1-il)pirimidin-4-ona, moduladores de la enzima estearoil-coa-desaturasa 1; procedimiento de preparacion; composicin farmaceutica; y uso en el tratamiento y profilaxis de la obesidad. | |
| ECSP10010379A (es) | Derivados de oxindol sustituido y su uso para el tratamiento de enfermedades dependientes de la vasopresina | |
| SE0301650D0 (sv) | Novel compounds | |
| CY1109803T1 (el) | Φαρμακευτικες συνθεσεις που βασιζονται σε ανταγωνιστες νκ2 για παιδιατρικη χρηση | |
| UA85563C2 (ru) | Конденсированные гетероциклические соединения | |
| GB0515025D0 (en) | Organic compounds | |
| TW200744607A (en) | Pyrimidine compounds as serotonin receptor modulators |